| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |